G-Quadruplex DNA and its Ligands in Anticancer Therapy

Medicinal Chemistry of Nucleic Acids

Volumn , Issue , 2011, Pages 206-257

  Huang, Zhi Shu ^a   Tan, Jia Heng ^a   Ou, Tian Miao ^a   Li, Ding ^a   Gu, Lian Quan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

DNA quadruplex research; G quadruplex DNA; G quadruplex ligands

Indexed keywords

EID: 84879686399     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118092804.ch5     Document Type: Chapter

References (271)

1. Hurley, L. H. (2002). DNA and its associated processes as targets for cancer therapy. Nature Reviews Cancer, 2 , 188-200.
2. Neidle, S., Parkinson, G. (2002). Telomere maintenance as a target for anticancer drug discovery. Nature Reviews Drug Discovery, 1 , 383-393.
3. Neidle, S., Thurston, D. E. (2005). Chemical approaches to the discovery and development of cancer therapies. Nature Reviews Cancer, 5 , 285-296.
4. Ou, T.-M., Lu, Y.-J., Tan, J.-H., Huang, Z.-S., Wong, K.-Y., Gu, L.-Q. (2008). G-quadruplexes: targets in anticancer drug design. ChemMedChem, 3 , 690-713.
5. Bates, P., Mergny, J.-L., Yang, D. (2007). Quartets in G-major. The first international meeting on quadruplex DNA. EMBO Reports, 8 , 1003-1010.
6. Wilson, W. D., Sugiyama, H. (2007). First international meeting on quadruplex. ACS Chemical Biology, 2 , 589-594.
7. Herbert, B.-S., Huppert, J. L., Johnson, F. B., Lane, A. N., Phan, A. T. (2009). Meeting report: second international meeting on quadruplex DNA. Biochimie, 91 , 1059-1065.
8. Gellert, M., Lipsett, M. N., Davies, D. R. (1962). Helix formation by guanylic acid. Proceedings of the National Academy of Sciences of the United States of America, 48 , 2013-2018.
9. Burge, S., Parkinson, G. N., Hazel, P., Todd, A. K., Neidle, S. (2006). Quadruplex DNA: sequence, topology and structure. Nucleic Acids Research, 34 , 5402-5415.
10. Phan, A. T., Kuryavyi, V., Patel, D. J. (2006). DNA architecture: from G to Z. Current Opinion in Structural Biology, 16 , 288-298.
11. Rhodes, D., Giraldo, R. (1995). Telomere structure and function. Current Opinion in Structural Biology, 5 , 311-322.
12. Williamson, J. R., Raghuraman, M. K., Cech, T. R. (1989). Monovalent cationinduced structure of telomeric DNA: the G-quartet model. Cell , 59 , 871-880.
13. Williamson, J. R. (1994). G-quartet structures in telomeric DNA. Annual Review of Biophysics and Biomolecular Structure, 23 , 703-730.
14. Davis, J. T. (2004). G-quartets 40 years later: from 5-GMP to molecular biology and supramolecular chemistry. Angewandte Chemie, International Edition, 43 , 668-698.
15. Simonsson, T. (2001). G-quadruplex DNA structures-variations on a theme. Biological Chemistry, 382 , 621-628.
16. Mills, M., Lacroix, L., Arimondo, P. B., Leroy, J.-L., Francois, J.-C., Klump, H., et al . (2002). Unusual DNA conformations: implications for telomeres. Current Medicinal Chemistry: Anti-Cancer Agents, 2 , 627-644.
17. Dai, J., Carver, M., Yang, D. (2008). Polymorphism of human telomeric quadruplex structures. Biochimie, 90 , 1172-1183.
18. Zhang, D.-H., Fujimoto, T., Saxena, S., Yu, H.-Q., Miyoshi, D., Sugimoto, N. (2010). Monomorphic RNA G-quadruplex and polymorphic DNA G-quadruplex structures responding to cellular environmental factors. Biochemistry, 49 , 4554-4563.
19. Huppert, J. L. (2008). Four-stranded nucleic acids: structure, function and targeting of G-quadruplexes. Chemical Society Reviews, 37 , 1375-1384.
20. Phan, A. T. (2010). Human telomeric G-quadruplex: structures of DNA and RNA sequences. FEBS Journal, 277 , 1107-1117.
21. Mohanty, D., Bansal, M. (1994). Conformational polymorphism in telomeric structures: loop orientation and interloop pairing in d(G4TnG4). Biopolymers, 34 , 1187-1211.
22. Zhang, N., Gorin, A., Majumdar, A., Kettani, A., Chernichenko, N., Skripkin, E., et al . (2001). V-shaped scaffold: a new architectural motif identified in an A·(G·G·G·G) pentad-containing dimeric DNA quadruplex involving stacked G(anti)·G(anti)·G(anti)·G(syn) Tetrads. Journal of Molecular Biology, 311 , 1063-1079.
23. Risitano, A., Fox Keith, R. (2004). Influence of loop size on the stability of intramolecular DNA quadruplexes. Nucleic Acids Research, 32 , 2598-2606.
24. Hazel, P., Huppert, J., Balasubramanian, S., Neidle, S. (2004). Loop-lengthdependent folding of G-quadruplexes. Journal of the American Chemical Society, 126 , 16405-16415.
25. Cevec, M., Plavec, J. (2005). Role of loop residues and cations on the formation and stability of dimeric DNA G-quadruplexes. Biochemistry, 44 , 15238-15246.
26. Rachwal, P. A., Brown, T., Fox, K. R. (2007). Sequence effects of single base loops in intramolecular quadruplex DNA. FEBS Letters, 581 , 1657-1660.
27. Rachwal, P. A., Findlow, I. S., Werner, J. M., Brown, T., Fox, K. R. (2007). Intramolecular DNA quadruplexes with different arrangements of short and long loops. Nucleic Acids Research, 35 , 4214-4222.
28. Mohanty, D., Bansal, M. (1993). Conformational polymorphism in G-tetraplex structures: strand reversal by base flipover or sugar flipover. Nucleic Acids Research, 21 , 1767-1774.
29. Dapic, V., Bates, P. J., Trent, J. O., Rodger, A., Thomas, S. D., Miller, D. M. (2002). Antiproliferative activity of G-quartet-forming oligonucleotides with backbone and sugar modifications. Biochemistry, 41 , 3676-3685.
30. Smith, F. W., Feigon, J. (1993). Strand orientation in the DNA quadruplex formed from the Oxytricha telomere repeat oligonucleotide d(G4T4G4) in solution. Biochemistry, 32 , 8682-8692.
31. Campbell, N. H., Parkinson, G. N. (2007). Crystallographic studies of quadruplex nucleic acids. Methods, 43 , 252-263.
32. Raghuraman, M. K., Cech, T. R. (1990). Effect of monovalent cation-induced telomeric DNA structure on the binding of Oxytricha telomeric protein. Nucleic Acids Research, 18 , 4543-4552.
33. Hud, N. V., Schultze, P., Sklenar, V., Feigon, J. (1999). Binding sites and dynamics of ammonium ions in a telomere repeat DNA quadruplex. Journal of Molecular Biology, 285 , 233-243.
34. Basu, S., Szewczak, A. A., Cocco, M., Strobel, S. A. (2000). Direct detection of monovalent metal ion binding to a DNA G-quartet by 205Tl NMR. Journal of the American Chemical Society, 122 , 3240-3241.
35. Rovnyak, D., Baldus, M., Wu, G., Hud, N. V., Feigon, J., Griffin, R. G. (2000). Localization of 23Na+ in a DNA quadruplex by high-field solid-state NMR. Journal of the American Chemical Society, 122 , 11423-11429.
36. Gill, M. L., Strobel, S. A., Loria, J. P. (2005). 205Tl NMR methods for the characterization of monovalent cation binding to nucleic acids. Journal of the American Chemical Society, 127 , 16723-16732.
37. Forman, S. L., Fettinger, J. C., Pieraccini, S., Gottarelli, G., Davis, J. T. (2000). Toward artificial ion channels: a lipophilic G-quadruplex. Journal of the American Chemical Society, 122 , 4060-4067.
38. Parkinson, G. N., Lee, M. P. H., Neidle, S. (2002). Crystal structure of parallel quadruplexes from human telomeric DNA. Nature, 417 , 876-880.
39. van Mourik, T., Dingley, A. J. (2005). Characterization of the monovalent ion position and hydrogen-bond network in guanine quartets by DFT calculations of NMR parameters. Chemistry-A European Journal, 11 , 6064-6079.
40. Ma, L., Iezzi, M., Kaucher, M. S., Lam, Y.-F., Davis, J. T. (2006). Cation exchange in lipophilic G-quadruplexes: not all ion binding sites are equal. Journal of the American Chemical Society, 128 , 15269-15277.
41. Kwan, I. C. M., Mo, X., Wu, G. (2007). Probing hydrogen bonding and ion-carbonyl interactions by solid-state 17O NMR spectroscopy: G-ribbon and G-quartet. Journal of the American Chemical Society, 129 , 2398-2407.
42. Wang, Y., Patel, D. J. (1993). Solution structure of the human telomeric repeat d[AG3(T2AG3)3] G-tetraplex. Structure, 1 , 263-282.
43. Redon, S., Bombard, S., Elizondo-Riojas, M. A., Chottard, J. C. (2003). Platinum cross-linking of adenines and guanines on the quadruplex structures of the AG3(T2AG3)3 and (T2AG3)4 human telomere sequences in Na+ and K+ solutions. Nucleic Acids Research, 31 , 1605-1613.
44. He, Y., Neumann, R. D., Panyutin, I. G. (2004). Intramolecular quadruplex conformation of human telomeric DNA assessed with 125I-radioprobing. Nucleic Acids Research, 32 , 5359-5367.
45. Lim, K. W., Amrane, S., Bouaziz, S., Xu, W., Mu, Y., Patel, D. J., Luu, K. N., Phan, A. T. (2009). Structure of the human telomere in K+ solution: a stable baskettype G-quadruplex with only two G-tetrad layers. Journal of the American Chemical Society, 131 , 4301-4309.
46. Luu, K. N., Phan, A. T., Kuryavyi, V., Lacroix, L., Patel, D. J. (2006). Structure of the human telomere in K+ solution: an intramolecular (3+1) G-quadruplex scaffold. Journal of the American Chemical Society, 128 , 9963-9970.
47. Ambrus, A., Chen, D., Dai, J., Bialis, T., Jones, R. A., Yang, D. (2006). Human telomeric sequence forms a hybrid-type intramolecular G-quadruplex structure with mixed parallel/antiparallel strands in potassium solution. Nucleic Acids Research, 34 , 2723-2735.
48. Dai, J., Punchihewa, C., Ambrus, A., Chen, D., Jones, R. A., Yang, D. (2007). Structure of the intramolecular human telomeric G-quadruplex in potassium solution: a novel adenine triple formation. Nucleic Acids Research, 35 , 2440-2450.
49. Matsugami, A., Xu, Y., Noguchi, Y., Sugiyama, H., Katahira, M. (2007). Structure of a human telomeric DNA sequence stabilized by 8-bromoguanosine substitutions, as determined by NMR in a K+ solution. FEBS Journal, 274 , 3545-3556.
50. Huppert, J. L., Balasubramanian, S. (2005). Prevalence of quadruplexes in the human genome. Nucleic Acids Research, 33 , 2908-2916.
51. Huppert, J. L., Balasubramanian, S. (2007). G-quadruplexes in promoters throughout the human genome. Nucleic Acids Research, 35 , 406-413.
52. Fernando, H., Sewitz, S., Darot, J., Tavare, S., Huppert, J. L., Balasubramanian, S. (2009). Genome-wide analysis of a G-quadruplex-specific single-chain antibody that regulates gene expression. Nucleic Acids Research, 37 , 6716-6722.
53. Du, Z., Zhao, Y., Li, N. (2009). Genome-wide colonization of gene regulatory elements by G4 DNA motifs. Nucleic Acids Research, 37 , 6784-6798.
54. Lipps, H. J., Rhodes, D. (2009). G-quadruplex structures: in vivo evidence and function. Trends in Cell Biology, 19 , 414-422.
55. Paeschke, K., Simonsson, T., Postberg, J., Rhodes, D., Lipps, H. J. (2005). Telomere end-binding proteins control the formation of G-quadruplex DNA structures in vivo. Nature Structural & Molecular Biology, 12 , 847-854.
56. Paeschke, K., Juranek, S., Simonsson, T., Hempel, A., Rhodes, D., Lipps, H. J. (2008). Telomerase recruitment by the telomere end binding protein-beta facilitates G-quadruplex DNA unfolding in ciliates. Nature Structural & Molecular Biology, 15 , 598-604.
57. Rawal, P., Kummarasetti, V. B. R., Ravindran, J., Kumar, N., Halder, K., Sharma, R., et al . (2006). Genome-wide prediction of G4 DNA as regulatory motifs: role in Escherichia coli global regulation. Genome Research, 16 , 644-655.
58. Verma, A., Yadav, V. K., Basundra, R., Kumar, A., Chowdhury, S. (2009). Evidence of genome-wide G4 DNA-mediated gene expression in human cancer cells. Nucleic Acids Research, 37 , 4194-4204.
59. Brooks, T. A., Hurley, L. H. (2009). The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics. Nature Reviews Cancer, 9 , 849-861.
60. Gonzalez, V., Hurley, L. H. (2010). The c-MYC NHE III1: function and regulation. Annual Review of Pharmacology and Toxicology, 50 , 111-129.
61. Davis, T. L., Firulli, A. B., Kinniburgh, A. J. (1989). Ribonucleoprotein and protein factors bind to an H-DNA-forming c-myc DNA element: possible regulators of the c-myc gene. Proceedings of the National Academy of Sciences of the United States of America, 86 , 9682-9686.
62. Berberich, S. J., Postel, E. H. (1995). PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive element. Oncogene, 10 , 2343-2347.
63. Simonsson, T., Pecinka, P., Kubista, M. (1998). DNA tetraplex formation in the control region of c-myc. Nucleic Acids Research, 26 , 1167-1172.
64. Phan, A. T., Modi, Y. S., Patel, D. J. (2004). Propeller-type parallel-stranded Gquadruplexes in the human c-myc promoter. Journal of the American Chemical Society, 126 , 8710-8716.
65. Ambrus, A., Chen, D., Dai, J., Jones, R. A., Yang, D. (2005). Solution structure of the biologically relevant G-quadruplex element in the human c-MYC promoter. Implications for G-quadruplex stabilization. Biochemistry, 44 , 2048-2058.
66. Siddiqui-Jain, A., Grand, C. L., Bearss, D. J., Hurley, L. H. (2002). Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proceedings of the National Academy of Sciences of the United States of America, 99 , 11593-11598.
67. Ou, T.-M., Lu, Y.-J., Zhang, C., Huang, Z.-S., Wang, X.-D., Tan, J.-H., et al . (2007). Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivatives. Journal of Medicinal Chemistry, 50 , 1465-1474.
68. Sun, D., Hurley, L. H. (2009). The importance of negative superhelicity in inducing the formation of G-quadruplex and i-motif structures in the c-myc promoter: implications for drug targeting and control of gene expression. Journal of Medicinal Chemistry, 52 , 2863-2874.
69. Duquette, M. L., Handa, P., Vincent, J. A., Taylor, A. F., Maizels, N. (2004). Intracellular transcription of G-rich DNAs induces formation of G-loops, novel structures containing G4 DNA. Genes & Development, 18 , 1618-1629.
70. Qin, Y., Hurley, L. H. (2008). Structures, folding patterns, and functions of intramolecular DNA G-quadruplexes found in eukaryotic promoter regions. Biochimie, 90 , 1149-1171.
71. Fry, M. (2007). Tetraplex DNA and its interacting proteins. Frontiers in Bioscience, 12 , 4336-4351.
72. Blackburn, E. H. (2001). Switching and signaling at the telomere. Cell , 106 , 661-673.
73. Moyzis, R. K., Buckingham, J. M., Cram, L. S., Dani, M., Deaven, L. L., Jones, M. D., et al . (1988). A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proceedings of the National Academy of Sciences of the United States of America, 85 , 6622-6626.
74. Makarov, V. L., Hirose, Y., Langmore, J. P. (1997). Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell , 88 , 657-666.
75. McElligott, R., Wellinger, R. J. (1997). The terminal DNA structure of mammalian chromosomes. EMBO Journal, 16 , 3705-3714.
76. Wright, W. E., Tesmer, V. M., Huffman, K. E., Levene, S. D., Shay, J. W. (1997). Normal human chromosomes have long G-rich telomeric overhangs at one end. Genes & Development, 11 , 2801-2809.
77. Harley, C. B., Futcher, A. B., Greider, C. W. (1990). Telomeres shorten during ageing of human fibroblasts. Nature, 345 , 458-460.
78. Stewart, S. A., Weinberg, R. A. (2006). Telomeres: cancer to human aging. Annual Review of Cell and Developmental Biology, 22 , 531-557.
79. Greider, C. W., Blackburn, E. H. (1985). Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell , 43 , 405-413.
80. Morin, G. B. (1989). The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell , 59 , 521-529.
81. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L., Coviello, G. M., Wright, W. E., Weinrich, S. L., Shay, J. W. (1994). Specific association of human telomerase activity with immortal cells and cancer. Science, 266 , 2011-2015.
82. Shay, J. W., Bacchetti, S. (1997). A survey of telomerase activity in human cancer. European Journal of Cancer, 33 , 787-791.
83. Bryan, T. M., Cech, T. R. (1999). Telomerase and the maintenance of chromosome ends. Current Opinion in Cell Biology, 11 , 318-324.
84. Masutomi, K., Yu, E. Y., Khurts, S., Ben-Porath, I., Currier, J. L., Metz, G. B., et al . (2003). Telomerase maintains telomere structure in normal human cells. Cell , 114 , 241-253.
85. Sun, D., Thompson, B., Cathers, B. E., Salazar, M., Kerwin, S. M., Trent, et al . (1997). Inhibition of human telomerase by a G-quadruplex-interactive compound. Journal of Medicinal Chemistry, 40 , 2113-2116.
86. Monchaud, D., Teulade-Fichou, M.-P. (2008). A hitchhiker's guide to G-quadruplex ligands. Organic & Biomolecular Chemistry, 6 , 627-636.
87. Tan, J.-H., Gu, L.-Q., Wu, J.-Y. (2008). Design of selective G-quadruplex ligands as potential anticancer agents. Mini-Reviews in Medicinal Chemistry, 8 , 1163-1178.
88. De Cian, A., Lacroix, L., Douarre, C., Temime-Smaali, N., Trentesaux, C., Riou, J.-F., et al . (2008). Targeting telomeres and telomerase. Biochimie, 90 , 131-155.
89. Neidle, S. (2010). Human telomeric G-quadruplex: the current status of telomeric G-quadruplexes as therapeutic targets in human cancer. FEBS Journal, 277 , 1118-1125.
90. Gomez, D., Aouali, N., Renaud, A., Douarre, C., Shin-ya, K., Tazi, J., et al . (2003). Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase. Cancer Research, 63 , 6149-6153.
91. Shammas, M. A., Shmookler Reis, R. J., Akiyama, M., Koley, H., Chauhan, D., Hideshima, T., et al . (2003). Telomerase inhibition and cell growth arrest by Gquadruplex interactive agent in multiple myeloma. Molecular Cancer Therapeutics, 2 , 825-833.
92. Binz, N., Shalaby, T., Rivera, P., Shin-ya, K., Grotzer, M. A. (2005). Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells. European Journal of Cancer, 41 , 2873-2881.
93. Zhou, J. M., Zhu, X. F., Lu, Y. J., Deng, R., Huang, Z. S., Mei, Y. P., et al . (2006). Senescence and telomere shortening induced by novel potent G-quadruplex interactive agents, quindoline derivatives, in human cancer cell lines. Oncogene, 25 , 503-511.
94. Leonetti, C., Amodei, S., D'Angelo, C., Rizzo, A., Benassi, B., Antonelli, A., et al . (2004). Biological activity of the G-quadruplex ligand RHPS4 (3,11difluoro-6,8,13- trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) is associated with telomere capping alteration. Molecular Pharmacology, 66 , 1138-1146.
95. Pennarun, G., Granotier, C., Gauthier, L. R., Gomez, D., Hoffschir, F., Mandine, E., et al . (2005). Apoptosis related to telomere instability and cell cycle alterations in human glioma cells treated by new highly selective G-quadruplex ligands. Oncogene, 24 , 2917-2928.
96. Phatak, P., Cookson, J. C., Dai, F., Smith, V., Gartenhaus, R. B., Stevens, M. F. G., et al . (2007). Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism. British Journal of Cancer, 96 , 1223-1233.
97. Gomez, D., O'Donohue, M.-F., Wenner, T., Douarre, C., Macadre, J., Koebel, P., et al . (2006). The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells. Cancer Research, 66 , 6908-6912.
98. Gomez, D., Wenner, T., Brassart, B., Douarre, C., O'Donohue, M.-F., El Khoury, V., et al . (2006). Telomestatin-induced telomere uncapping is modulated by POT1 through G-overhang extension in HT1080 human tumor cells. Journal of Biological Chemistry, 281 , 38721-38729.
99. Salvati, E., Leonetti, C., Rizzo, A., Scarsella, M., Mottolese, M., Galati, R., et al. (2007). Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect. Journal of Clinical Investigation, 117 , 3236-3247.
100. Rizzo, A., Salvati, E., Porru, M., D'Angelo, C., Stevens, M. F., D'Incalci, M., et al . (2009). Stabilization of quadruplex DNA perturbs telomere replication leading to the activation of an ATR-dependent ATM signaling pathway. Nucleic Acids Research, 37 , 5353-5364.
101. Dang, C. V., O'Donnell, K. A., Zeller, K. I., Nguyen, T., Osthus, R. C., Li, F. (2006). The c-Myc target gene network. Seminars in Cancer Biology, 16 , 253-264.
102. Dang, C. V., Resar, L. M., Emison, E., Kim, S., Li, Q., Prescott, J. E., et al . (1999). Function of the c-Myc oncogenic transcription factor. Experimental Cell Research, 253 , 63-77.
103. Tomonaga, T., Levens, D. (1995). Heterogeneous nuclear ribonucleoprotein K is a DNA-binding transactivator. Journal of Biological Chemistry, 270 , 4875-4881.
104. Michelotti, E. F., Tomonaga, T., Krutzsch, H., Levens, D. (1995). Cellular nucleic acid binding protein regulates the CT element of the human c-myc protooncogene. Journal of Biological Chemistry, 270 , 9494-9499.
105. Majello, B., De Luca, P., Suske, G., Lania, L. (1995). Differential transcriptional regulation of c-myc promoter through the same DNA binding sites targeted by Sp1-like proteins. Oncogene, 10 , 1841-1848.
106. Rankin, S., Reszka, A. P., Huppert, J., Zloh, M., Parkinson, G. N., Todd, A. K., et al. (2005). Putative DNA quadruplex formation within the human c-kit oncogene. Journal of the American Chemical Society, 127 , 10584-10589.
107. Dexheimer, T. S., Sun, D., Hurley, L. H. (2006). Deconvoluting the structural and drug-recognition complexity of the G-quadruplex-forming region upstream of the bcl-2P1 promoter. Journal of the American Chemical Society, 128 , 5404-5415.
108. Wang, X.-D., Ou, T.-M., Lu, Y.-J., Li, Z., Xu, Z., Xi, C., et al . (2010). Turning off transcription of the bcl-2 gene by stabilizing the bcl-2 promoter quadruplex with quindoline derivatives. Journal of Medicinal Chemistry, 53 , 4390-4398.
109. Cogoi, S., Paramasivam, M., Filichev, V., Geci, I., Pedersen, E. B., Xodo, L. E. (2009). Identification of a new G-quadruplex motif in the KRAS promoter and design of pyrene-modified G4-decoys with antiproliferative activity in pancreatic cancer cells. Journal of Medicinal Chemistry, 52 , 564-568.
110. Paramasivam, M., Membrino, A., Cogoi, S., Fukuda, H., Nakagama, H., Xodo, L. E. (2009). Protein hnRNP A1 and its derivative Up1 unfold quadruplex DNA in the human KRAS promoter: implications for transcription. Nucleic Acids Research, 37 , 2841-2853.
111. Palumbo, S. M. L., Ebbinghaus, S. W., Hurley, L. H. (2009). Formation of a unique end-to-end stacked pair of G-quadruplexes in the hTERT core promoter with implications for inhibition of telomerase by G-quadruplex-interactive ligands. Journal of the American Chemical Society, 131 , 10878-10891.
112. Grummt, I. (1999). Regulation of mammalian ribosomal gene transcription by RNA polymerase I. Progress in Nucleic Acid Research and Molecular Biology, 62 , 109-154.
113. Hanakahi, L. A., Sun, H., Maizels, N. (1999). High affinity interactions of nucleolin with G-G-paired rDNA. Journal of Biological Chemistry, 274 , 15908-15912.
114. Drygin, D., Siddiqui-Jain, A., O'Brien, S., Schwaebe, M., Lin, A., Bliesath, J., et al. (2009). Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis. Cancer Research, 69 , 7653-7661.
115. Srivastava, M., Pollard, H. B. (1999). Molecular dissection of nucleolin's role in growth and cell proliferation: new insights. The FASEB Journal, 13 , 1911-1922.
116. Rickards, B., Flint, S. J., Cole, M. D., LeRoy, G. (2007). Nucleolin is required for RNA polymerase I transcription in vivo. Molecular and Cellular Biology, 27 , 937-948.
117. Storck, S., Thiry, M., Bouvet, P. (2009). Conditional knockout of nucleolin in DT40 cells reveals the functional redundancy of its RNA-binding domains. Biology of the Cell , 101 , 153-167.
118. Montanaro, L., Trere, D., Derenzini, M. (2008). Nucleolus, ribosomes, and cancer. American Journal of Pathology, 173 , 301-310.
119. White, R. J. (2008). RNA polymerases I and III, non-coding RNAs and cancer. Trends in Genetics, 24 , 622-629.
120. Hershman, S. G., Chen, Q., Lee, J. Y., Kozak, M. L., Yue, P., Wang, L.-S., et al . (2008). Genomic distribution and functional analyses of potential G-quadruplexforming sequences in Saccharomyces cerevisiae. Nucleic Acids Research, 36 , 144-156.
121. Haider, S. M., Parkinson, G. N., Neidle, S. (2003). Structure of a G-quadruplexligand complex. Journal of Molecular Biology, 326 , 117-125.
122. Campbell, N. H., Parkinson, G. N., Reszka, A. P., Neidle, S. (2008). Structural basis of DNA quadruplex recognition by an acridine drug. Journal of the American Chemical Society, 130 , 6722-6724.
123. Campbell, N. H., Patel, M., Tofa, A. B., Ghosh, R., Parkinson, G. N., Neidle, S. (2009). Selectivity in ligand recognition of G-quadruplex loops. Biochemistry, 48 , 1675-1680.
124. Clark, G. R., Pytel, P. D., Squire, C. J., Neidle, S. (2003). Structure of the first parallel DNA quadruplex-drug complex. Journal of the American Chemical Society, 125 , 4066-4067.
125. Gavathiotis, E., Heald, R. A., Stevens, M. F. G., Searle, M. S. (2003). Drug recognition and stabilisation of the parallel-stranded DNA quadruplex d(TTAGGGT)4 containing the human telomeric repeat. Journal of Molecular Biology, 334 , 25-36.
126. Phan, A. T., Kuryavyi, V., Gaw, H. Y., Patel, D. J. (2005). Small-molecule interaction with a five-guanine-tract G-quadruplex structure from the human MYC promoter. Nature Chemical Biology, 1 , 167-173.
127. Parkinson, G. N., Ghosh, R., Neidle, S. (2007). Structural basis for binding of porphyrin to human telomeres. Biochemistry, 46 , 2390-2397.
128. Parkinson, G. N., Cuenca, F., Neidle, S. (2008). Topology conservation and loop flexibility in quadruplex-drug recognition: crystal structures of inter- and intramolecular telomeric DNA quadruplex-drug complexes. Journal of Molecular Biology, 381 , 1145-1156.
129. Cocco, M. J., Hanakahi, L. A., Huber, M. D., Maizels, N. (2003). Specific interactions of distamycin with G-quadruplex DNA. Nucleic Acids Research, 31 , 2944-2951.
130. Martino, L., Virno, A., Pagano, B., Virgilio, A., Di Micco, S., Galeone, A., et al . (2007). Structural and thermodynamic studies of the interaction of distamycin A with the parallel quadruplex structure [d(TGGGGT)]4. Journal of the American Chemical Society, 129 , 16048-16056.
131. Cosconati, S., Marinelli, L., Trotta, R., Virno, A., De Tito, S., Romagnoli, R., et al . (2010). Structural and conformational requisites in DNA quadruplex groove binding: another piece to the puzzle. Journal of the American Chemical Society, 132 , 6425-6433.
132. Phan, A. T., Kuryavyi, V., Burge, S., Neidle, S., Patel, D. J. (2007). Structure of an unprecedented G-quadruplex scaffold in the human c-kit promoter. Journal of the American Chemical Society, 129 , 4386-4392.
133. Perry, P. J., Gowan, S. M., Reszka, A. P., Polucci, P., Jenkins, T. C., Kelland, L. R., et al . (1998). 1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase. Journal of Medicinal Chemistry, 41 , 3253-3260.
134. Perry, P. J., Reszka, A. P., Wood, A. A., Read, M. A., Gowan, S. M., Dosanjh, H. S., et al . (1998). Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones. Journal of Medicinal Chemistry, 41 , 4873-4884.
135. Huang, H.-S., Chen, I.-B., Huang, K.-F., Lu, W.-C., Shieh, F.-Y., Huang, Y.-Y., et al . (2007). Synthesis and human telomerase inhibition of a series of regioisomeric disubstituted amidoanthraquinones. Chemical & Pharmaceutical Bulletin, 55 , 284-292.
136. Huang, H.-S., Huang, K.-F., Li, C.-L., Huang, Y.-Y., Chiang, Y.-H., Huang, F.-C., et al . (2008). Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives. Bioorganic & Medicinal Chemistry, 16 , 6976-6986.
137. Zagotto, G., Sissi, C., Lucatello, L., Pivetta, C., Cadamuro, S. A., Fox, K. R., et al . (2008). Aminoacyl-anthraquinone conjugates as telomerase inhibitors: synthesis, biophysical and biological evaluation. Journal of Medicinal Chemistry, 51 , 5566-5574.
138. Perry, P. J., Jenkins, T. C. (2001). DNA tetraplex-binding drugs: structure-selective targeting is critical for antitumour telomerase inhibition. Mini-Reviews in Medicinal Chemistry, 1 , 31-41.
139. Neidle, S., Read, M. A. (2000). G-quadruplexes as therapeutic targets. Biopolymers, 56 , 195-208.
140. Zagotto, G., Sissi, C., Moro, S., Dal Ben, D., Parkinson, G. N., Fox, K. R., et al . (2008). Amide bond direction modulates G-quadruplex recognition and telomerase inhibition by 2,6 and 2,7 bis-substituted anthracenedione derivatives. Bioorganic & Medicinal Chemistry, 16 , 354-361.
141. Harrison, R. J., Gowan, S. M., Kelland, L. R., Neidle, S. (1999). Human telomerase inhibition by substituted acridine derivatives. Bioorganic & Medicinal Chemistry Letters, 9 , 2463-2468.
142. Read, M. A.,Wood, A. A., Harrison, J. R., Gowan, S. M., Kelland, L. R., Dosanjh, H. S., et al . (1999). Molecular modeling studies on G-quadruplex complexes of telomerase inhibitors: structure-activity relationships. Journal of Medicinal Chemistry, 42 , 4538-4546.
143. Laronze-Cochard, M., Kim, Y.-M., Brassart, B., Riou, J.-F., Laronze, J.-Y., Sapi, J. (2009). Synthesis and biological evaluation of novel 4,5-bis(dialkylaminoalkyl)- substituted acridines as potent telomeric G-quadruplex ligands. European Journal of Medicinal Chemistry, 44 , 3880-3888.
144. Harrison, R. J., Reszka, A. P., Haider, S. M., Romagnoli, B., Morrell, J., Read, M. A., et al . (2004). Evaluation of by disubstituted acridone derivatives as telomerase inhibitors: the importance of G-quadruplex binding. Bioorganic & Medicinal Chemistry Letters, 14 , 5845-5849.
145. Read, M., Harrison, R. J., Romagnoli, B., Tanious, F. A., Gowan, S. H., Reszka, et al . (2001). Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors. Proceedings of the National Academy of Sciences of the United States of America, 98 , 4844-4849.
146. Harrison, R. J., Cuesta, J., Chessari, G., Read, M. A., Basra, S. K., Reszka, A. P., et al . (2003). Trisubstituted acridine derivatives as potent and selective telomerase inhibitors. Journal of Medicinal Chemistry, 46 , 4463-4476.
147. Moore, M. J. B., Schultes, C. M., Cuesta, J., Cuenca, F., Gunaratnam, M., Tanious, F. A., et al . (2006). Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation. Journal of Medicinal Chemistry, 49 , 582-599.
148. Schultes, C. M., Guyen, B., Cuesta, J., Neidle, S. (2004). Synthesis, biophysical and biological evaluation of 3,6-bis-amidoacridines with extended 9-anilino substituents as potent G-quadruplex-binding telomerase inhibitors. Bioorganic & Medicinal Chemistry Letters, 14 , 4347-4351.
149. Gowan, S. M., Harrison, J. R., Patterson, L., Valenti, M., Read, M. A., Neidle, S., et al . (2002). A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity. Molecular Pharmacology, 61 , 1154-1162.
150. Gunaratnam, M., Greciano, O., Martins, C., Reszka, A. P., Schultes, C. M., Morjani, H., et al . (2007). Mechanism of acridine-based telomerase inhibition and telomere shortening. Biochemical Pharmacology, 74 , 679-689.
151. Incles, C. M., Schultes, C. M., Kempski, H., Koehler, H., Kelland, L. R., Neidle, S. (2004). A G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cells. Molecular Cancer Therapeutics, 3 , 1201-1206.
152. Burger, A. M., Dai, F., Schultes, C. M., Reszka, A. P., Moore, M. J., Double, J. A., et al . (2005). The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function. Cancer Research, 65 , 1489-1496.
153. Kelland, L. R. (2005). Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics-current status and future prospects. European Journal of Cancer, 41 , 971-979.
154. Incles, C. M., Schultes, C. M., Kelland, L. R., Neidle, S. (2003). Acquired cellular resistance to flavopiridol in a human colon carcinoma cell line involves up-regulation of the telomerase catalytic subunit and telomere elongation. Sensitivity of resistant cells to combination treatment with a telomerase inhibitor. Molecular Pharmacology, 64 , 1101-1108.
155. Taetz, S., Baldes, C., Muerdter, T. E., Kleideiter, E., Piotrowska, K., Bock, U., et al . (2006). Biopharmaceutical characterization of the telomerase inhibitor BRACO19. Pharmaceutical Research, 23 , 1031-1037.
156. Taetz, S., Muerdter, T. E., Zapp, J., Boettcher, S., Baldes, C., Kleideiter, E., et al . (2008). Decomposition of the telomere-targeting agent BRACO19 in physiological media results in products with decreased inhibitory potential. International Journal of Pharmaceutics, 357 , 6-14.
157. Lauhon, C. T., Szostak, J. W. (1995). RNA aptamers that bind flavin and nicotinamide redox cofactors. Journal of the American Chemical Society, 117 , 1246-1257.
158. Bejugam, M., Sewitz, S., Shirude, P. S., Rodriguez, R., Shahid, R., Balasubramanian, S. (2007). Trisubstituted isoalloxazines as a new class of G-quadruplex binding ligands: small molecule regulation of c-kit oncogene expression. Journal of the American Chemical Society, 129 , 12926-12927.
159. Perry, P. J., Read, M. A., Davies, R. T., Gowan, S. M., Reszka, A. P., Wood, A. A., et al . (1999). 2,7-disubstituted amidofluorenone derivatives as inhibitors of human telomerase. Journal of Medicinal Chemistry, 42 , 2679-2684.
160. Alcaro, S., Artese, A., Iley, J. N., Maccari, R., Missailidis, S., Ortuso, F., et al . (2007). Tetraplex DNA specific ligands based on the fluorenone-carboxamide scaffold. Bioorganic & Medicinal Chemistry Letters, 17 , 2509-2514.
161. Alcaro, S., Artese, A., Iley, J. N., Missailidis, S., Ortuso, F., Parrotta, L., et al . (2010). Rational design, synthesis, biophysical and antiproliferative evaluation of fluorenone derivatives with DNA G-quadruplex binding properties. ChemMedChem, 5 , 575-583.
162. Paritala, H., Firestine, S. M. (2009). Benzo(h)quinoline derivatives as G-quadruplex binding agents. Bioorganic & Medicinal Chemistry Letters, 19 , 1584-1587.
163. Nielsen, M. C., Borch, J., Ulven, T. (2009). Design, synthesis and evaluation of 4,7-diamino-1,10-phenanthroline G-quadruplex ligands. Bioorganic & Medicinal Chemistry, 17 , 8241-8246.
164. Koeppel, F., Riou, J.-F., Laoui, A., Mailliet, P., Arimondo, P. B., Labit, D., et al . (2001). Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes. Nucleic Acids Research, 29 , 1087-1096.
165. Caprio, V., Guyen, B., Opoku-Boahen, Y., Mann, J., Gowan, S., Kelland, L. M., et al . (2000). A novel inhibitor of human telomerase derived from 10H-indolo[3,2- b]quinoline. Bioorganic & Medicinal Chemistry Letters, 10 , 2063-2066.
166. Guyen, B., Schultes, C. M., Hazel, P., Mann, J., Neidle, S. (2004). Synthesis and evaluation of analogs of 10H-indolo[3,2-b]quinoline as G-quadruplex stabilizing ligands and potential inhibitors of the enzyme telomerase. Organic & Biomolecular Chemistry, 2 , 981-988.
167. Zhou, J.-L., Lu, Y.-J., Ou, T.-M., Zhou, J.-M., Huang, Z.-S., Zhu, X.-F., et al . (2005). Synthesis and evaluation of quindoline derivatives as G-quadruplex inducing and stabilizing ligands and potential inhibitors of telomerase. Journal of Medicinal Chemistry, 48 , 7315-7321.
168. Lu, Y.-J., Ou, T.-M., Tan, J.-H., Hou, J.-Q., Shao, W.-Y., Peng, D., et al . (2008). 5- N-methylated quindoline derivatives as telomeric G-quadruplex stabilizing ligands: effects of 5-N positive charge on quadruplex binding affinity and cell proliferation. Journal of Medicinal Chemistry, 51 , 6381-6392.
169. Liu, J. N., Deng, R., Guo, J. F., Zhou, J. M., Feng, G. K., Huang, Z. S., et al . (2007). Inhibition of myc promoter and telomerase activity and induction of delayed apoptosis by SYUIQ-5, a novel G-quadruplex interactive agent in leukemia cells. Leukemia, 21 , 1300-1302.
170. Zhou, W.-J., Deng, R., Zhang, X.-Y., Feng, G.-K., Gu, L.-Q., Zhu, X.-F. (2009). G-quadruplex ligand SYUIQ-5 induces autophagy by telomere damage and TRF2 delocalization in cancer cells. Molecular Cancer Therapeutics, 8 , 3203-3213.
171. Hooda, J., Bednarski, D., Irish, L., Firestine, S. M. (2006). Synthesis and testing of a triaza-cyclopenta[b]phenanthrene scaffold as a DNA binding agent. Bioorganic & Medicinal Chemistry, 14 , 1902-1909.
172. Heald, R. A., Modi, C., Cookson, J. C., Hutchinson, I., Laughton, C. A., Gowan, S. M., et al . (2002). Antitumor polycyclic acridines. 8. Synthesis and telomeraseinhibitory activity of methylated pentacyclic acridinium salts. Journal of Medicinal Chemistry, 45 , 590-597.
173. Guittat, L., De Cian, A., Rosu, F., Gabelica, V., De Pauw, E., Delfourne, E., et al . (2005). Ascididemin and meridine stabilise G-quadruplexes and inhibit telomerase in vitro. Biochimica et Biophysica Acta, General Subjects, 1724 , 375-384.
174. Gowan, S. M., Heald, R., Stevens, M. F. G., Kelland, L. R. (2001). Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes. Molecular Pharmacology, 60 , 981-988.
175. Cookson, J. C., Dai, F., Smith, V., Heald, R. A., Laughton, C. A., Stevens, M. F. G., et al . (2005). Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents. Molecular Pharmacology, 68 , 1551-1558.
176. Biroccio, A., Rizzo, A., Elli, R., Koering, C.-E., Belleville, A., Benassi, B., et al . (2006). TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells. European Journal of Cancer, 42 , 1881-1888.
177. Leonetti, C., Scarsella, M., Riggio, G., Rizzo, A., Salvati, E., D'Incalci, M., et al . (2008). G-quadruplex ligand RHPS4 potentiates the antitumor activity of camptothecins in preclinical models of solid tumors. Clinical Cancer Research, 14 , 7284-7291.
178. Cookson, J. C., Heald, R. A., Stevens, M. F. G. (2005). Antitumor polycyclic acridines. 17. Synthesis and pharmaceutical profiles of pentacyclic acridinium salts designed to destabilize telomeric integrity. Journal of Medicinal Chemistry, 48 , 7198-7207.
179. Cheng, M.-K., Modi, C., Cookson, J. C., Hutchinson, I., Heald, R. A., McCarroll, A. J., et al . (2008). Antitumor polycyclic acridines. 20. Search for DNA quadruplex binding selectivity in a series of 8,13-dimethylquino[4,3,2-kl]acridinium salts: telomere-targeted agents. Journal of Medicinal Chemistry, 51 , 963-975.
180. Mergny, J.-L., Lacroix, L., Teulade-Fichou, M.-P., Hounsou, C., Guittat, L., Hoarau, M., et al . (2001). Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay. Proceedings of the National Academy of Sciences of the United States of America, 98 , 3062-3067.
181. Hounsou, C., Guittat, L., Monchaud, D., Jourdan, M., Saettel, N., Mergny, J.-L., et al. (2007). G-quadruplex recognition by quinacridines: a SAR, NMR, and biological study. ChemMedChem, 2 , 655-666.
182. Debray, J., Zeghida, W., Jourdan, M., Monchaud, D., Dheu-Andries, M.-L., Dumy, P., et al . (2009). Synthesis and evaluation of fused bispyrimidinoacridines as novel pentacyclic analogues of quadruplex-binder BRACO-19. Organic & Biomolecular Chemistry, 7 , 5219-5228.
183. Alberti, P., Schmitt, P., Nguyen, C.-H., Rivalle, C., Hoarau, M., Grierson, D. S., et al . (2002). Benzoindoloquinolines interact with DNA tetraplexes and inhibit telomerase. Bioorganic & Medicinal Chemistry Letters, 12 , 1071-1074.
184. Cetinkol Ozgul, P., Engelhart Aaron, E., Nanjunda Rupesh, K., Wilson, W. D., Hud Nicholas, V. (2008). Submicromolar, selective g-quadruplex ligands from one pot: thermodynamic and structural studies of human telomeric DNA binding by azacyanines. Chembiochem, 9 , 1889-1892.
185. Yamakuchi,M., Nakata, M., Kawahara, K.-i., Kitajima, I., Maruyama, I. (1997). New quinolones, ofloxacin and levofloxacin, inhibit telomerase activity in transitional cell carcinoma cell lines. Cancer Letters, 119 , 213-219.
186. Duan, W., Rangan, A., Vankayalapati, H., Kim, M.-Y., Zeng, Q., Sun, D., et al . (2001). Design and synthesis of fluoroquinophenoxazines that interact with human telomeric G-quadruplexes and their biological effects. Molecular Cancer Therapeutics, 1 , 103-120.
187. Kim, M.-Y., Duan, W., Gleason-Guzman, M., Hurley, L. H. (2003). Design, synthesis, and biological evaluation of a series of fluoroquinoanthroxazines with contrasting dual mechanisms of action against topoisomerase II and G-quadruplexes. Journal of Medicinal Chemistry, 46 , 571-583.
188. Kern, J. T., Wang, T. P., Kerwin, S. M. (2002). The relationship between ligand aggregation and G-quadruplex DNA selectivity in a series of 3,4,9,10- perylenetetracarboxylic acid diimides. Biochemistry, 41 , 11379-11389.
189. Kerwin, S. M., Chen, G., Kern, J. T., Thomas, P. W. (2002). Perylene diimide Gquadruplex DNA binding selectivity is mediated by ligand aggregation. Bioorganic & Medicinal Chemistry Letters, 12 , 447-450.
190. Sissi, C., Lucatello, L., Paul Krapcho, A., Maloney, D. J., Boxer, M. B., Camarasa, M. V., et al . (2007). Tri-, tetra- and heptacyclic perylene analogues as new potential antineoplastic agents based on DNA telomerase inhibition. Bioorganic & Medicinal Chemistry, 15 , 555-562.
191. Tuntiwechapikul, W., Lee, J. T., Salazar, M. (2001). Design and synthesis of the G-quadruplex-specific cleaving reagent perylene-EDTA·iron(II). Journal of the American Chemical Society, 123 , 5606-5607.
192. Samudrala, R., Zhang, X., Wadkins, R. M., Mattern, D. L. (2007). Synthesis of a non-cationic, water-soluble perylenetetracarboxylic diimide and its interactions with G-quadruplex-forming DNA. Bioorganic & Medicinal Chemistry, 15 , 186-193.
193. Kern, J. T., Kerwin, S. M. (2002). The aggregation and G-quadruplex DNA selectivity of charged 3,4,9,10-perylenetetracarboxylic acid diimides. Bioorganic & Medicinal Chemistry Letters, 12 , 3395-3398.
194. Franceschin, M., Alvino, A., Casagrande, V., Mauriello, C., Pascucci, E., Savino, M., et al . (2007). Specific interactions with intra- and intermolecular G-quadruplex DNA structures by hydrosoluble coronene derivatives: a new class of telomerase inhibitors. Bioorganic & Medicinal Chemistry, 15 , 1848-1858.
195. Cuenca, F., Greciano, O., Gunaratnam, M., Haider, S., Munnur, D., Nanjunda, R., et al . (2008). Tri- and tetra-substituted naphthalene diimides as potent G-quadruplex ligands. Bioorganic & Medicinal Chemistry Letters, 18 , 1668-1673.
196. Gunaratnam, M., Swank, S., Haider, S. M., Galesa, K., Reszka, A. P., Beltran, M., et al. (2009). Targeting human gastrointestinal stromal tumor cells with a quadruplexbinding small molecule. Journal of Medicinal Chemistry, 52 , 3774-3783.
197. Wheelhouse, R. T., Sun, D., Han, H., Han, F. X., Hurley, L. H. (1998). Cationic porphyrins as telomerase inhibitors: the interaction of tetra(N-methyl-4- pyridyl)porphine with quadruplex DNA. Journal of the American Chemical Society, 120 , 3261-3262.
198. Han, H., Langley, D. R., Rangan, A., Hurley, L. H. (2001). Selective interactions of cationic porphyrins with G-quadruplex structures. Journal of the American Chemical Society, 123 , 8902-8913.
199. Seenisamy, J., Rezler, E. M., Powell, T. J., Tye, D., Gokhale, V., Joshi, C. S., et al . (2004). The dynamic character of the G-quadruplex element in the c-MYC promoter and modification by TMPyP4. Journal of the American Chemical Society, 126 , 8702-8709.
200. Ren, J., Chaires, J. B. (1999). Sequence and structural selectivity of nucleic acid binding ligands. Biochemistry, 38 , 16067-16075.
201. Izbicka, E., Wheelhouse, R. T., Raymond, E., Davidson, K. K., Lawrence, R. A., Sun, D., et al . (1999). Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells. Cancer Research, 59 , 639-644.
202. Kim, M.-Y., Gleason-Guzman, M., Izbicka, E., Nishioka, D., Hurley, L. H. (2003). The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures. Cancer Research, 63 , 3247-3256.
203. Grand, C. L., Han, H., Munoz, R. M., Weitman, S., Von Hoff, D. D., Hurley, L. H., et al . (2002). The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo. Molecular Cancer Therapeutics, 1 , 565-573.
204. Sun, D., Guo, K., Rusche, J. J., Hurley, L. H. (2005). Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents. Nucleic Acids Research, 33 , 6070-6080.
205. Sun, D., Liu,W.-J., Guo, K., Rusche, J. J., Ebbinghaus, S., Gokhale, V., et al . (2008). The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex-interactive agents. Molecular Cancer Therapeutics, 7 , 880-889.
206. Guo, K., Pourpak, A., Beetz-Rogers, K., Gokhale, V., Sun, D., Hurley, L. H. (2007). Formation of pseudosymmetrical G-quadruplex and i-Motif structures in the proximal promoter region of the RET oncogene. Journal of the American Chemical Society, 129 , 10220-10228.
207. Qin, Y., Rezler, E. M., Gokhale, V., Sun, D., Hurley, L. H. (2007). Characterization of the G-quadruplexes in the duplex nuclease hypersensitive element of the PDGF-A promoter and modulation of PDGF-A promoter activity by TMPyP4. Nucleic Acids Research, 35 , 7698-7713.
208. Mikami-Terao, Y., Akiyama, M., Yuza, Y., Yanagisawa, T., Yamada, O., Yamada, H. (2008). Antitumor activity of G-quadruplex-interactive agent TMPyP4 in K562 leukemic cells. Cancer Letters, 261 , 226-234.
209. Wang, P., Ren, L., He, H., Liang, F., Zhou, X., Tan, Z. (2006). A phenol quaternary ammonium porphyrin as a potent telomerase inhibitor by selective interaction with quadruplex DNA. ChemBioChem, 7 , 1155-1159.
210. Dixon, I. M., Lopez, F., Tejera, A. M., Esteve, J.-P., Blasco, M. A., Pratviel, G., et al . (2007). A G-quadruplex ligand with 10000-fold selectivity over duplex DNA. Journal of the American Chemical Society, 129 , 1502-1503.
211. Goncalves, D. P. N., Rodriguez, R., Balasubramanian, S., Sanders, J. K. M. (2006). Tetramethylpyridiniumporphyrazines-a new class of G-quadruplex inducing and stabilizing ligands. Chemical Communication, 4685-4687.
212. Ren, L., Zhang, A., Huang, J., Wang, P., Weng, X., Zhang, L., et al . (2007). Quaternary ammonium zinc phthalocyanine: inhibiting telomerase by stabilizing G quadruplexes and inducing G-quadruplex structure transition and formation. Chem- BioChem, 8 , 775-780.
213. Alzeer, J., Vummidi, B. R., Roth, P. J. C., Luedtke, N. W. (2009). Guanidiniummodified phthalocyanines as high-affinity G-quadruplex fluorescent probes and transcriptional regulators. Angewandte Chemie, International Edition, 48 , 9362-9365, S9362/9361-S9362/9316.
214. Yaku, H., Murashima, T., Miyoshi, D., Sugimoto, N. (2010). Anionic phthalocyanines targeting G-quadruplexes and inhibiting telomerase activity in the presence of excessive DNA duplexes. Chemical Communication, 46 , 5740-5742.
215. Fu, B., Huang, J., Ren, L., Weng, X., Zhou, Y., Du, Y., et al . (2007). Cationic corrole derivatives: a new family of G-quadruplex inducing and stabilizing ligands. Chemical Communications, 3264-3266.
216. Ma, H., Zhang, M., Zhang, D., Huang, R., Zhao, Y., Yang, H., et al . (2010). Pyridylsubstituted corrole isomers: synthesis and their regulation to G-quadruplex structures. Chem.-Asian J ., 5 , 114-122.
217. Shin-ya, K., Wierzba, K., Matsuo, K.-i., Ohtani, T., Yamada, Y., Furihata, K., et al . (2001). Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus. Journal of the American Chemical Society, 123 , 1262-1263.
218. Kim, M.-Y., Vankayalapati, H., Shin-ya, K., Wierzba, K., Hurley, L. H. (2002). Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular G-quadruplex. Journal of the American Chemical Society, 124 , 2098-2099.
219. Rosu, F., Gabelica, V., Shin-ya, K., De Pauw, E. (2003). Telomestatin-induced stabilization of the human telomeric DNA quadruplex monitored by electrospray mass spectrometry. Chemical Communications, 2702-2703.
220. Moorhouse, A. D., Santos, A. M., Gunaratnam, M., Moore, M., Neidle, S., Moses, J. E. (2006). Stabilization of G-quadruplex DNA by highly selective ligands via click chemistry. Journal of the American Chemical Society, 128 , 15972-15973.
221. Shammas, M. A., Reis, R. J. S., Li, C., Koley, H., Hurley, L. H., Anderson, K. C., et al . (2004). Telomerase inhibition and cell growth arrest after telomestatin treatment in multiple myeloma. Clinical Cancer Research, 10 , 770-776.
222. Gomez, D., Paterski, R., Lemarteleur, T., Shin-ya, K., Mergny, J.-L., Riou, J.-F. (2004). Interaction of telomestatin with the telomeric single-strand overhang. Journal of Biological Chemistry, 279 , 41487-41494.
223. Tahara, H., Shin-Ya, K., Seimiya, H., Yamada, H., Tsuruo, T., Ide, T. (2006). Gquadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3telomeric overhang in cancer cells. Oncogene, 25 , 1955-1966.
224. Tauchi, T., Shin-ya, K., Sashida, G., Sumi, M., Nakajima, A., Shimamoto, T., et al . (2003). Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways. Oncogene, 22 , 5338-5347.
225. Tauchi, T., Shin-ya, K., Sashida, G., Sumi, M., Okabe, S., Ohyashiki, J. H., et al . (2006). Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia. Oncogene, 25 , 5719-5725.
226. Nakajima, A., Tauchi, T., Sashida, G., Sumi, M., Abe, K., Yamamoto, K., et al . (2003). Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy. Leukemia, 17 , 560-567.
227. Sumi, M., Tauchi, T., Sashida, G., Nakajima, A., Gotoh, A., Shin-Ya, K., et al . (2004). A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia. International Journal of Oncology, 24 , 1481-1487.
228. Minhas, G. S., Pilch, D. S., Kerrigan, J. E., LaVoie, E. J., Rice, J. E. (2006). Synthesis and G-quadruplex stabilizing properties of a series of oxazole-containing macrocycles. Bioorganic & Medicinal Chemistry Letters, 16 , 3891-3895.
229. Rzuczek, S. G., Pilch, D. S., LaVoie, E. J., Rice, J. E. (2008). Lysinyl macrocyclic hexaoxazoles: synthesis and selective G-quadruplex stabilizing properties. Bioorganic & Medicinal Chemistry Letters, 18 , 913-917.
230. Satyanarayana, M., Rzuczek, S. G., LaVoie, E. J., Pilch, D. S., Liu, A., Liu, L. F., et al . (2008). Ring-closing metathesis for the synthesis of a highly G-quadruplex selective macrocyclic hexaoxazole having enhanced cytotoxic potency. Bioorganic & Medicinal Chemistry Letters, 18 , 3802-3804.
231. Tera, M., Ishizuka, H., Takagi, M., Suganuma, M., Shin-ya, K., Nagasawa, K. (2008). Macrocyclic hexaoxazoles as sequence- and mode-selective G-quadruplex binders. Angewandte Chemie, International Edition, 47 , 5557-5560.
232. Tera, M., Iida, K., Ishizuka, H., Takagi, M., Suganuma, M., Doi, T., et al . (2009). Synthesis of a potent G-quadruplex-binding macrocyclic heptaoxazole. Chem- BioChem, 10 , 431-435.
233. Satyanarayana, M., Kim, Y.-A., Rzuczek, S. G., Pilch, D. S., Liu, A. A., Liu, L. F., et al . (2010). Macrocyclic hexaoxazoles: influence of aminoalkyl substituents on RNA and DNA G-quadruplex stabilization and cytotoxicity. Bioorganic & Medicinal Chemistry Letters, 20 , 3150-3154.
234. Rzuczek, S. G., Pilch, D. S., Liu, A., Liu, L., La Voie, E. J., Rice, J. E. (2010). Macrocyclic pyridyl polyoxazoles: selective RNA and DNA G-quadruplex ligands as antitumor agents. Journal of Medicinal Chemistry, 53 , 3632-3644.
235. Barbieri, C. M., Srinivasan, A. R., Rzuczek, S. G., Rice, J. E., LaVoie, E. J., Pilch, D. S. (2007). Defining the mode, energetics and specificity with which a macrocyclic hexaoxazole binds to human telomeric G-quadruplex DNA. Nucleic Acids Research, 35 , 3272-3286.
236. Pilch, D. S., Barbieri, C. M., Rzuczek, S. G., LaVoie, E. J., Rice, J. E. (2008). Targeting human telomeric G-quadruplex DNA with oxazole-containing macrocyclic compounds. Biochimie, 90 , 1233-1249.
237. Tsai, Y.-C., Qi, H., Lin, C.-P., Lin, R.-K., Kerrigan, J. E., Rzuczek, S. G., et al . (2009). A G-quadruplex stabilizer induces M-phase cell cycle arrest. Journal of Biological Chemistry, 284 , 22535-22543.
238. Seenisamy, J., Bashyam, S., Gokhale, V., Vankayalapati, H., Sun, D., Siddiqui-Jain, A., et al . (2005). Design and synthesis of an expanded porphyrin that has selectivity for the c-MYC G-quadruplex structure. Journal of the American Chemical Society, 127 , 2944-2959.
239. Baker, E. S., Lee, J. T., Sessler, J. L., Bowers, M. T. (2006). Cyclo[n]pyrroles: size and site-specific binding to G-quadruplexes. Journal of the American Chemical Society, 128 , 2641-2648.
240. Shirude, P. S., Gillies, E. R., Ladame, S., Godde, F., Shin-ya, K., Huc, I., et al . (2007). Macrocyclic and helical oligoamides as a new class of G-quadruplex ligands. Journal of the American Chemical Society, 129 , 11890-11891.
241. Jantos, K., Rodriguez, R., Ladame, S., Shirude, P. S., Balasubramanian, S. (2006). Oxazole-based peptide macrocycles: a new class of G-quadruplex binding ligands. Journal of the American Chemical Society, 128 , 13662-13663.
242. Agarwal, T., Roy, S., Chakraborty, T. K., Maiti, S. (2010). Furan based cyclic homo-oligopeptides bind G-quadruplex selectively and repress c-MYC transcription. Bioorganic & Medicinal Chemistry Letters, 20 , 4346-4349.
243. Chen, Q., Kuntz, I. D., Shafer, R. H. (1996). Spectroscopic recognition of guanine dimeric hairpin quadruplexes by a carbocyanine dye. Proceedings of the National Academy of Sciences of the United States of America, 93 , 2635-2639.
244. Moore, M. J. B., Cuenca, F., Searcey, M., Neidle, S. (2006). Synthesis of distamycin A polyamides targeting G-quadruplex DNA. Organic & Biomolecular Chemistry, 4 , 3479-3488.
245. White, E. W., Tanious, F., Ismail, M. A., Reszka, A. P., Neidle, S., Boykin, D. W., et al . (2007). Structure-specific recognition of quadruplex DNA by organic cations: influence of shape, substituents and charge. Biophysical Chemistry, 126 , 140-153.
246. Kaluzhny, D. N., Borisova, O. F., Shchyolkina, A. K. (2009). Diverse modes of 5-[4- (aminoiminomethyl)phenyl]-[2,2-bifuran]-5-carboximidamide (DB832) interaction with multi-stranded DNA structures. Biopolymers, 93 , 8-20.
247. Rahman, K. M., Reszka, A. P., Gunaratnam, M., Haider, S. M., Howard, P. W., Fox, K. R., et al . (2009). Biaryl polyamides as a new class of DNA quadruplex-binding ligands. Chemical Communication, 4097-4099.
248. Gomez, D., Mergny, J.-L., Riou, J.-F. (2002). Detection of telomerase inhibitors based on G-quadruplex ligands by a modified telomeric repeat amplification protocol assay. Cancer Research, 62 , 3365-3368.
249. Gunaratnam, M., Green, C., Moreira, J. B., Moorhouse, A. D., Kelland, L. R., Moses, J. E., et al . (2009). G-quadruplex compounds and cis-platin act synergistically to inhibit cancer cell growth in vitro and in vivo. Biochemical Pharmacology, 78 , 115-122.
250. Wheelhouse, R. T., Jennings, S. A., Phillips, V. A., Pletsas, D., Murphy, P. M., Garbett, N. C., et al . (2006). Design, synthesis, and evaluation of novel biarylpyrimidines: a new class of ligand for unusual nucleic acid structures. Journal of Medicinal Chemistry, 49 , 5187-5198.
251. Dash, J., Shirude, P. S., Balasubramanian, S. (2008). G-quadruplex recognition by bis-indole carboxamides. Chemical Communications, 3055-3057.
252. Li, G., Huang, J., Zhang, M., Zhou, Y., Zhang, D., Wu, Z., et al . (2008). Bis(benzimidazole)pyridine derivative as a new class of G-quadruplex inducing and stabilizing ligand. Chemical Communications, 4564-4566.
253. Waller, Z. A. E., Shirude, P. S., Rodriguez, R., Balasubramanian, S. (2008). Triarylpyridines: a versatile small molecule scaffold for G-quadruplex recognition. Chemical Communications, 1467-1469.
254. Dash, J., Shirude, P. S., Hsu, S.-T. D., Balasubramanian, S. (2008). Diarylethynyl amides that recognize the parallel conformation of genomic promoter DNA Gquadruplexes. Journal of the American Chemical Society, 130 , 15950-15956.
255. Drewe, W. C., Nanjunda, R., Gunaratnam, M., Beltran, M., Parkinson, G. N., Reszka, A. P., et al . (2008). Rational design of substituted diarylureas: a scaffold for binding to G-quadruplex motifs. Journal of Medicinal Chemistry, 51 , 7751-7767.
256. El Bakali, J., Klupsch, F., Guedin, A., Brassart, B., Fontaine, G., Farce, A., et al . (2009). 2,6-diphenylthiazolo[3,2-b][1,2,4]triazoles as telomeric G-quadruplex stabilizers. Bioorganic & Medicinal Chemistry Letters, 19 , 3434-3438.
257. Rodriguez, R., Muller, S., Yeoman, J. A., Trentesaux, C., Riou, J.-F., Balasubramanian, S. (2008). A novel small molecule that alters shelterin integrity and triggers a DNA-damage response at telomeres. Journal of the American Chemical Society, 130 , 15758-15759.
258. Moses, J. E., Ritson, D. J., Zhang, F., Lombardo, C. M., Haider, S., Oldham, N., et al . (2010). A click chemistry approach to C3 symmetric, G-quadruplex stabilising ligands. Organic & Biomolecular Chemistry, 8 , 2926-2930.
259. Franceschin, M., Rossetti, L., D'Ambrosio, A., Schirripa, S., Bianco, A., Ortaggi, G., et al . (2006). Natural and synthetic G-quadruplex interactive berberine derivatives. Bioorganic & Medicinal Chemistry Letters, 16 , 1707-1711.
260. Zhang, W.-J., Ou, T.-M., Lu, Y.-J., Huang, Y.-Y., Wu, W.-B., Huang, Z.-S., et al . (2007). 9-Substituted berberine derivatives as G-quadruplex stabilizing ligands in telomeric DNA. Bioorganic & Medicinal Chemistry, 15 , 5493-5501.
261. Ma, Y., Ou, T.-M., Hou, J.-Q., Lu, Y.-J., Tan, J.-H., Gu, L.-Q., et al . (2008). 9- N-Substituted berberine derivatives: stabilization of G-quadruplex DNA and downregulation of oncogene c-myc. Bioorganic & Medicinal Chemistry, 16 , 7582-7591.
262. Ma, Y., Ou, T.-M., Tan, J.-H., Hou, J.-Q., Huang, S.-L., Gu, L.-Q., et al . (2009). Synthesis and evaluation of 9-O-substituted berberine derivatives containing azaaromatic terminal group as highly selective telomeric G-quadruplex stabilizing ligands. Bioorganic & Medicinal Chemistry Letters, 19 , 3414-3417.
263. Tan, J.-H., Ou, T.-M., Hou, J.-Q., Lu, Y.-J., Huang, S.-L., Luo, H.-B., et al . (2009). Isaindigotone derivatives: a new class of highly selective ligands for telomeric Gquadruplex DNA. Journal of Medicinal Chemistry, 52 , 2825-2835.
264. Georgiades, S. N., Abd Karim, N. H., Suntharalingam, K., Vilar, R. (2010). Interaction of metal complexes with G-quadruplex DNA. Angewandte Chemie, International Edition, 49 , 4020-4034.
265. Schouten, J. A., Ladame, S., Mason, S. J., Cooper, M. A., Balasubramanian, S. (2003). G-quadruplex-specific peptide-hemicyanine ligands by partial combinatorial selection. Journal of the American Chemical Society, 125 , 5594-5595.
266. Teulade-Fichou, M.-P., Carrasco, C., Guittat, L., Bailly, C., Alberti, P., Mergny, J.-L., et al . (2003). Selective recognition of G-quadruplex telomeric DNA by a bis(quinacridine) macrocycle. Journal of the American Chemical Society, 125 , 4732-4740.
267. De Cian, A., Delemos, E., Mergny, J.-L., Teulade-Fichou, M.-P., Monchaud, D. (2007). Highly efficient G-quadruplex recognition by bisquinolinium compounds. Journal of the American Chemical Society, 129 , 1856-1857.
268. Redman, J. E., Granadino-Roldan, J. M., Schouten, J. A., Ladame, S., Reszka, A. P., Neidle, S., et al . (2009). Recognition and discrimination of DNA quadruplexes by acridine-peptide conjugates. Organic & Biomolecular Chemistry, 7 , 76-84.
269. Huang, J., Li, G., Wu, Z., Song, Z., Zhou, Y., Shuai, L., et al . (2009). Bisbenzimidazole to benzobisimidazole: from binding B-form duplex DNA to recognizing different modes of telomere G-quadruplex. Chemical Communication, 902-904.
270. Fu, Y.-T., Keppler, B. R., Soares, J., Jarstfer, M. B. (2009). BRACO19 analog dimers with improved inhibition of telomerase and hPot 1. Bioorganic & Medicinal Chemistry, 17 , 2030-2037.
271. Brassart, B., Gomez, D., De Cian, A., Paterski, R., Montagnac, A., Qui, K.-H., et al. (2007). A new steroid derivative stabilizes G-quadruplexes and induces telomere uncapping in human tumor cells. Molecular Pharmacology, 72 , 631-640.